Characteristics and Future Perspectives of Available Electronic Health Record Databases in Japan
{{output}}
The global use of real-world data (RWD) for drug approval and post-marketing surveillance has increased significantly. During 2023 and 2024, the US Food and Drug Administration issued industry guidance, and the European Medicines Agency released real-world evi... ...
